Paul A. Volberding | Akateeminen Kirjakauppa

The latest in the crucial series documenting scientific discoveries at the forefront of HIV and AIDS research!
This volume updates the most important and controversial issues facing physicians, nurses, microbiologists, pharmacists, and epidemiologists who deal directly with patients suffering from HIV and AIDS, focusing on specific areas in which important new advances have occurred in diagnosis, therapy, and prevention of infection and related complications.
Outlines new disease management strategies being tested in prospective clinical trials and observational studies!
Combining elements of virology, epidemiology, immunology, oncology, endocrinology, neurology, psychiatry, and the behavioral sciences, AIDS Clinical Review 2000/2001

clarifies substantive advancements in vaccine development, realistically assessing potential efficacy and limitations

explores short-term antiretroviral therapy for dramatically reducing the rate of vertical transmission from mother to child

evaluates the efficacy of antiretroviral prophylaxis for workers who experience high-risk exposure to HIV-infected blood

discusses preservation of HIV specific immunity when antiretroviral therapy is initiated early in the course of acute infection

considers complex drug interactions that occur when drugs are used in combination

highlights cytokine and other immune-based therapies

suggests chronic hepatitis may ultimately be more fatal than HIV for coinfected patients

and more!
Including results recently presented at scientific meetings but not yet published in peer-reviewed journals, AIDS Clinical Review 2000/2001 is essential reading for infectious disease specialists, epidemiologists, virologists, immunologists, pharmacologists, microbiologists, hematologists, hepatologists, oncologists, neurologists, medical students in these disciplines, and all medical professionals involved in both AIDS research and clinical practice.